MIG - Press Review

 

2021

Alternativer Text

Süddeutsche Zeitung -

Cold as Ice against the big Players

Portrait of Quantum Computing Start-up IQM, a MIG portfolio company.
Find out more
Alternativer Text

Trend -

„This will be a big thing“

Online-interview with Dr. Matthias Kromayer, General Partner MIG AG, in leading Austrian Magazine „Trend“ about the future of Biotech and the portfolio of MIG Fonds.
Find out more
Alternativer Text

Bayerische Staatszeitung -

„Quantum Computer are committing errors all the time"

Interview with Dr. Jan Goetz, CEO of IQM, a MIG portfolio company, about the opportunities and limits of Quantum Computing.
Find out more
Alternativer Text

Frankfurter Allgemeine Zeitung -

Private Equity for small money

„FAZ“ is analyzing opportunities and risks of MIG Fonds.
Fiind out more
Alternativer Text

Tagesschau.de -

Pro and Con of vaccinations of children

„tagesschau.de“ discusses aspects of vaccionations of children against Covid-19 – with quotes of Dr. Matthias Kromayer, General Partner MIG AG
Find out more
Alternativer Text

Handelsblatt -

Macron demands till 2030 ten 100-Billion-Euro Start-ups

As part of a conference president Macron calls till 2030 the construction of ten European start-ups with a valuation of 100 Billion Euro. Among the participants Dr. Jan Goetz, CEO of IQM, a MIG portfolio company.
Find out more
Alternativer Text

Handelsblatt -

Unexpected Growth

„Handelsblatt“ reports about the increasing significance of SiC technology for DAX firm Infineon. Base was the acquisition of Siltectra, a former MIG portfolio company.
Find out more
Alternativer Text

Frankfurter Allgemeine Zeitung -

Qutac – German Industry forms alliance in Quantum Computing

„FAZ“ reports about Qutac, a project of the German industry refering Quantum Computing. MIG portfolio company IQM is part of Qutac.
Find out more
Alternativer Text

VC Magazin -

The Young Wild from the North

Trade Magazine „VC Magazin“ portrays MIG portfolio company GWA Hygiene as an example of start-ups in Northern Germany
Find out more
Alternativer Text

Wirtschaftswoche -

Sun, Beach – and now Start-ups

„Wirtschaftswoche“ describes the founders scene in Mecklenburg-Vorpommern with quotes of Tobias Gebhardt, CEO GWA Hygiene GmbH, a MIG portfolio company.
Find out more
Alternativer Text

Tagesschau.de -

Technologies of the Future

ARD reports about biotechnology in Germany with a statement of Michael Motschmann, General Partner MIG AG.
Mehr erfahren
Alternativer Text

Going Public, Transkript -

MIG: AMSilk Raises 29M Euro in Series C Funding

Several media report about the newest funding for AMSilk.
Find out more
Find out more
Alternativer Text

Financial Times und WELT -

Angela Merkel rejects US move to waive patents on vaccines

Among others „Financial Times“ and „DIE WELT“ report about the discussion to waive patents on Covid-19 vaccines, including quotes of Dr. Matthias Kromayer, General Partner MIG AG.
Find out more
Find out more
Alternativer Text

Börsen Zeitung, Finanzwelt, et al. -

MIG reports best year in history

Several media report about the best year in history of MIG AG
Find out more
Find out more
Find out more
Alternativer Text

Abendzeitung -

„Politics should create incentives“

Interview with Michael Motschmann, General Partner MIG AG, in „Abendzeitung“ about the future of German Biotech.
Alternativer Text

Tagesschau.de -

Advantage for mRNA-Vaccines

"tagesschau.de" has a look at the future of vaccinations against Covid-19 with quotes of Dr. Matthias Kromayer, General Partner MIG AG.
Mehr erfahren
Alternativer Text

dpa -

Biotech expects

German News Agency "dpa" reports about the Biotech Business in Germany with quotes of Michael Motschmann, General Partner MIG AG. Around 150 media published the article of dpa, among them ...
Mehr erfahren
Alternativer Text

Münchner Merkur -

How to bring buildings into a computer

„Münchner Merkur“ portrays NavVis, a MIG-portfolio company.
Alternativer Text

Manager Magazin -

Quantum Computing – it starts to be serious

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.
Find out more
Alternativer Text

Manager Magazin -

Biontech Investors put on Quantum Computing

„Manager Magazin Online“ reports about the assignment of Helmut Jeggle as Member of the Supervisory Board of IQM. The article mentions MIG Fonds and Michael Motschmann, Gneneral Partner of MIG AG, as first investor of the Finnish-German Start-up in Quantum Computing.
Find out more
Alternativer Text

Süddeutsche Zeitung -

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.
Find out more
Alternativer Text

VC Magazin -

„Investors got their money seven times back“

Interview with Michael Motschmann, General Partner of MIG AG, in „VC-Magazin“ about the investment in BioNTech
Find out more
Alternativer Text

Manager Magazin -

Going viral

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.
Alternativer Text

DIE WELT -

„What in Germany is possible“ and „The Heroes of the German Vaccine Fairy Tale“

„DIE WELT“ describes the development of MIG portfolio company BioNTech und the founders. The article refers to the role of Michael Motschmann and Dr. Matthias Kromayer, General Partner of MIG AG. Additionally an interview in „DIE WELT“ with Michael Motschmann.
Find out more
Alternativer Text

Handelsblatt -

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing
Find out more
Alternativer Text

Börse Online -

Success with molecules

In an article about Biotech IPOs in the US, „Börse Online“ quotes Dr. Matthias Kromayer, General Partner MIG AG.
Find out more
Alternativer Text

Wirtschaftswoche -

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.
Find out more
Alternativer Text

Handelsblatt -

Serious deficits

Angela Merkel and other heads of government claim a digital pact. Dr. Jan Goetz, CEO of MIG portfolio company IQM, calls for an European approach to Quantum Computing.
Find out more
Alternativer Text

BioCentury -

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.
Find out more
Alternativer Text

Tagesschau.de -

Many ideas, little money

„tagesschau.de“ reports about investments in Biotech in Germany and quotes Michael Motschmann, General Partner MIG AG.
Find out more
Alternativer Text

Finanzwelt, VC Magazin -

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.
Find out more
Find out more
Alternativer Text

CHEManager -

The Deals of German Biotech Investors

Trade Magazin „CHEManager“ reports about German Investors in Biotech, among them MIGs investments.
Find out more
Alternativer Text

Börsen Zeitung -

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG
Alternativer Text

Finanzwelt -

MIG Fonds expand in the French Alps

„Finanzwelt“ reports about a new investment of MIG Fonds in Zadient Technologies.
Find out more
Alternativer Text

Financial Times, Reuters, Manager Magazine et al -

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.
Find out more
Find out more
Find out more
Find out more
Find out more
Alternativer Text

Manager Magazin -

Everything started with a dream

„Manager Magazin“ interviews Michael Motschmann, General Partner of MIG AG, and Co-Investors Thomas Strüngmann and Helmut Jeggle about their joint involvement at BioNTech SE.
Find out more
Alternativer Text

Handelsblatt -

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.
Find out more
Alternativer Text

Frankfurter Allgemeine Zeitung -

Screen Supplier to sell

„FAZ“ reports about the start of a trade sale of Cynora, a portfolio company of MIG Fonds.